par Deuffic-Burban, Sylvie;Mathurin, Philippe;Rosa, Isabelle;Bouvier, Anne-Marie;Cannesson, Amélie;Mourad, Abbas;Canva, Valérie;Louvet, Alexandre;Deltenre, Pierre
;Boleslawski, Emmanuel;Truant, Stéphanie;Pruvot, François-René;Dharancy, Sébastien
Référence Digestive and Liver Disease, 46, 2, page (157-163)
Publication Publié, 2014-02
;Boleslawski, Emmanuel;Truant, Stéphanie;Pruvot, François-René;Dharancy, SébastienRéférence Digestive and Liver Disease, 46, 2, page (157-163)
Publication Publié, 2014-02
Article révisé par les pairs
| Résumé : | In light of the impact of emerging hepatitis C virus treatments on morbidity and mortality, we sought to determine whether candidates for liver transplantation for hepatocellular carcinoma and decompensated cirrhosis will decrease sufficiently to match liver grafts for hepatitis C virus-infected patients. |



